Skip to main content
Log in

One Year Follow-Up of Women Opting for Presymptomatic Testing for BRCA1 and BRCA2: Emotional Impact of the Test Outcome and Decisions on Risk Management (Surveillance or Prophylactic Surgery)

  • Conference Report
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Genetic testing enables women at risk for hereditary breast and/or ovarian cancer to find out whether they have inherited the gene mutation (BRCA1/BRCA2), and if so, to opt for frequent surveillance and/or prophylactic surgery (bilateral mastectomy and/or oophorectomy). Here, a follow-up is described for 63 healthy women at 50% risk of being a BRCA1/BRCA2 mutation carrier who underwent genetic testing. The course of distress and problems regarding body image and sexuality up to 1 year after disclosure of the test-outcome were described separately for mutation carriers undergoing mastectomy (n = 14), for mutation carriers opting for surveillance (n = 12) and for non-mutation carriers (n = 37). Furthermore, we analyzed whether women opting for prophylactic mastectomy differed from those opting for close surveillance with respect to biographical characteristics, experiences with cancer in relatives and personality. Women opting for prophylactic mastectomy had significantly higher distress levels than mutation carriers who opted for surveillance, and the non-mutation carriers. This difference in levels of distress was highest at pre- and post-test and had almost disappeared at 1-year follow-up. Besides, mutation carriers opting for prophylactic mastectomy were more often in their thirties, more often had young children and had a longer awareness of the genetic nature of cancer in the family than those opting for regular surveillance. Adverse effects were observed in women who underwent prophylactic mastectomy (mostly in combination with immediate breast reconstruction) regarding the perception of how their breast region looked like and felt, the intimate relationship and physical wellbeing whereas women opting for prophylactic mastectomy reported more distress than the other women in the study, their distress levels had significantly decreased 6 months or longer after surgery, possibly due to the significant risk reduction of developing breast cancer. This might explain, why most women who underwent prophylactic mastectomy were satisfied with this decision, despite a perceived negative impact on body image, the intimate relationship and physical wellbeing.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266: 66–71, 1994

    Google Scholar 

  2. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J: Identification of the breast cancer susceptibility gene BRCA2. Nature 378: 789–792, 1995

    Google Scholar 

  3. Meijers-Heijboer EJ, Verhoog LC, Brekelmans CTM, Seynaeve C, Tilanus-Linthorst MMA, Wagner A: Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation. Lancet 355: 2015–2020, 2000

    Google Scholar 

  4. Wagner TMU, Möslinger R, Langbauer G, Ahner R, The Austrian Hereditary Breast and Ovarian Cancer Group: Attitude towards prophylactic surgery and effects of genetic counseling in families with BRCA mutations. Br J Cancer 82: 1249–1253, 2000

    Google Scholar 

  5. Stefanek ME, Helzlsouer KJ, Wilcox PM, Houn F: Predictors of and satisfaction with bilateral prophylactic mastectomy. Prev Med 24: 412–419, 1995

    Google Scholar 

  6. Borgen PI, Hill AD, Tran KN, Van Zee KJ, Massie MJ, Payne D: Patient regrets after bilateral prophylactic mastectomy. Ann Surg Oncol 5: 603–606, 1998

    Google Scholar 

  7. Payne DK, Biggs C, Tran KN, Borgen PI, Massie MJ: Women's regrets after bilateral prophylactic mastectomy. Ann Surg Oncol 7: 150–154, 2000

    Google Scholar 

  8. Moyer A, Verhovsek H, Wilson VL: Facilitating the shift to population-based public health programs: innovation through the use of framework and logic model tools. Can J Public Health 88: 95–98, 1997

    Google Scholar 

  9. Aaronson NK, Bartelink H, van Dongen JA, van Dam FSAM: Evaluation of breast conserving therapy: clinical, methodological and psychological perspective. Eur J Surg Onc 14: 133–140, 1988

    Google Scholar 

  10. Dudok de Wit AC, Tibben A, Duivenvoorden HJ, Frets PG, Zoeteweij MW: Psychological distress in applicants for predictive DNA testing for autosomal dominant, heritable, late onset disorders. The Rotterdam/Leiden Genetics Workgroup. J Med Genet 34: 382–390, 1997

    Google Scholar 

  11. Tibben A, Timman R, Bannink EC, Duivenvoorden HJ: Threeyear follow-up after presymptomatic testing for Huntington's disease in tested individuals and partners. Health Psychol 16: 20–35, 1997

    Google Scholar 

  12. Lodder LN, Frets PG, Trijsburg RW, Meijers-Heijboer EJ, Klijn JGM, Duivenvoorden HJ: Presymptomatic testing for BRCA1 and BRCA2: How distressing are the pre-test weeks? J Med Gen 36: 906–913, 1999

    Google Scholar 

  13. Bleiker EM, van der Ploeg HM, Hendriks JH, Ader HJ: Personality factors and breast cancer development: a prospective longitudinal study. J Natl Cancer Inst 88: 1478–1482, 1996

    Google Scholar 

  14. Scheier MF, Carver CS: Optimism, coping, and health: Assessment and implications of generalized outcome expectancies. Health Psychology 4: 219–247, 1985

    Google Scholar 

  15. Zigmond AS, Snaith RP: The Hospital Anxiety and Depression Scale. Acta Psychiatrica Scandinavica 67: 361–370, 1983

    Google Scholar 

  16. Channer KS, Papouchado M, James MA, Rees JR: Anxiety and depression in patients with chest pain referred for exercise testing. Lancet 2: 820–323, 1985

    Google Scholar 

  17. Spinhoven PH, Ormel J, Sloekers PPA, Kempen GIJM: A validation study of the Hospital Anxiety and Depression scale (HADS) in different groups of Dutch subjects. Psychological Med 27: 363–370, 1997

    Google Scholar 

  18. Arrindell WA, Ettema H: dimensional structure, reliability and validity of the Dutch version of the Symptom Checklist (SCL-90): data based on a phobic and a 'normal' population. Nederlands Tijdschrift voor de Psychologie en Haar Grensgebieden 36: 77–108, 1981

    Google Scholar 

  19. Derogatis LR, Rickels K, Rock AF: The SCL-90 and the MMPI: a step in the validation of a new self-report scale. Br J Psychiat 128: 280–289, 1976

    Google Scholar 

  20. Horowitz MJ, Wilner N, Alvarez W: Impact of event scale: a measure of subjective stress. Psychosomatic Med 41: 209–218, 1979

    Google Scholar 

  21. DudokdeWit AC, Tibben A, Frets PG, Meijers-Heijboer EJ, Devilee P, Klijn JG: BRCA1 in the family: a case description of the psychological implications. Am J Med Genet 71: 63–71, 1997

    Google Scholar 

  22. Hopwood P: The assessment of body image in cancer patients. Eur J Cancer 29A: 276–281, 1993

    Google Scholar 

  23. Cull AM: The assessment of sexual function in cancer patients. Eur J Cancer 28A: 1680–1686, 1992

    Google Scholar 

  24. Gibbons RD, Hedeker DR, Elkin I, Waternaux C, Kraemer HC, Greenhouse JB: Some conceptual and statistical issues in analysis of longitudinal psychiatric data: application to the NIMH Treatment of Depression Collaborative Research Program dataset. Archives General Psychiat 50: 739–750, 1993

    Google Scholar 

  25. Little RJA, Rubin DB: Statistical Analysis with Missing Data. Wiley, New York, 1987

    Google Scholar 

  26. Meiser B, Butow P, Friedlander M, Schnieden V, Gattas M: Intention to undergo prophylactic bilateral mastectomy in women at increased risk of developing hereditary breast cancer. J Clin Oncol 18: 2250–2257, 2000

    Google Scholar 

  27. Lodder LN, Frets PG, Trijsburg RW, Meijers-Heijboer EJ, Klijn JGM, Duivenvoorden HJ: The psychological impact of receiving a BRCA1/BRCA2 test result. Am J Med Genet 98: 15–24, 2000

    Google Scholar 

  28. Lerman C, Hughes C, Lemon SJ, Main D, Snyder C, Durham C: What you don't know can hurt you: adverse psychologic effects in members of BRCA1-linked and BRCA2-linked families who decline genetic testing. J Clin Oncol 16: 1650–1654, 1998

    Google Scholar 

  29. Croyle RT, Smith KR, Botkin JR, Baty B: Psychological responses to BRCA1 mutation testing: preliminary findings. Health Psychol 16: 63–72, 1997

    Google Scholar 

  30. Festinger L: A Theory of Cognitive Dissonance. Stanford University Press, Stanford, CA, USA, 1957, 291

    Google Scholar 

  31. Contant CM, van Wersch AM, Wiggers T, Wai RT, van Geel AN: Motivations, satisfaction, and information of immediate breast reconstruction following mastectomy. Patient Educ Couns 40: 201–208, 2000

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lodder, L.N., Frets, P.G., Trijsburg, R.W. et al. One Year Follow-Up of Women Opting for Presymptomatic Testing for BRCA1 and BRCA2: Emotional Impact of the Test Outcome and Decisions on Risk Management (Surveillance or Prophylactic Surgery). Breast Cancer Res Treat 73, 97–112 (2002). https://doi.org/10.1023/A:1015269620265

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1015269620265

Navigation